Royal Prima PT Market Cap ($24.15 Million)
Market Cap & Net Worth: Royal Prima PT (PRIM)
Royal Prima PT market cap. Royal Prima PT (JK:PRIM) has a market capitalization of $24.15 Million (Rp412.16 Billion) as of November 6, 2026. Listed on the JK stock exchange, this Indonesia-based company holds position #24330 globally and #492 in its home market, demonstrating a -1.61% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Royal Prima PT's stock price Rp122.00 by its total outstanding shares 3378320205 (3.38 Billion). Also see PRIM cash flow conversion for how efficiently the company converts equity into cash flow.
Royal Prima PT Market Cap History (2018–2026)
Royal Prima PT market cap history from 2018 to 2026. Data shows change from $119.76 Million to $24.15 Million (-19.27% CAGR). Check Royal Prima PT share price for real-time trading data and today's change.
Index Memberships
Royal Prima PT is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Jakarta Stock Exchange Composite Index
JKSE
|
$406.66 Billion | 0.01% | #481 of 864 |
Weight: Royal Prima PT's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Royal Prima PT Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Royal Prima PT's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset momentum of Royal Prima PT to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
Royal Prima PT's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $119.76 Million | $204.79 Billion | $17.21 Billion | 0.00x | 0.01x |
| 2019 | $83.14 Million | $174.22 Billion | $2.40 Billion | 0.00x | 0.03x |
| 2020 | $45.93 Million | $260.59 Billion | $38.17 Billion | 0.00x | 0.00x |
| 2021 | $79.18 Million | $599.96 Billion | $75.43 Billion | 0.00x | 0.00x |
| 2022 | $34.25 Million | $261.93 Billion | $21.59 Billion | 0.00x | 0.00x |
| 2023 | $17.42 Million | $265.34 Billion | -$2.75 Billion | 0.00x | N/A |
| 2024 | $11.09 Million | $299.36 Billion | -$18.41 Billion | 0.00x | N/A |
Competitor Companies of PRIM by Market Capitalization
Companies near Royal Prima PT in the global market cap rankings as of November 6, 2026. Also see PRIM asset base for a full breakdown of the balance sheet.
Key companies related to Royal Prima PT by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #280 globally with a market cap of $91.34 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #895 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #985 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1208 globally with a market cap of $20.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #280 | HCA Healthcare, Inc. | NYSE:HCA | $91.34 Billion | $507.48 |
| #895 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €51.87 |
| #985 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1208 | Tenet Healthcare Corporation | NYSE:THC | $20.93 Billion | $286.46 |
Market Capitalization of Royal Prima PT (2018–2026)
Market capitalization of Royal Prima PT from 2018 to today. Between 2018 and today, Royal Prima PT's market cap moved from $119.76 Million to $ 24.15 Million, with a yearly change of -19.27%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rp24.15 Million | +46.99% |
| 2025 | Rp16.43 Million | +48.21% |
| 2024 | Rp11.09 Million | -36.36% |
| 2023 | Rp17.42 Million | -49.13% |
| 2022 | Rp34.25 Million | -56.75% |
| 2021 | Rp79.18 Million | +72.41% |
| 2020 | Rp45.93 Million | -44.76% |
| 2019 | Rp83.14 Million | -30.58% |
| 2018 | Rp119.76 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 6th, 2026 the market cap of Royal Prima PT was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $24.15 Million USD |
| MoneyControl | $24.15 Million USD |
| MarketWatch | $24.15 Million USD |
| marketcap.company | $24.15 Million USD |
| Reuters | $24.15 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Royal Prima PT
PT Royal Prima Tbk engages in providing hospital services in Indonesia. The company operates its hospitals under the Royal Prima Medan, Royal Prima Jambi, and RSU Royal Prima Marelan names. It provides health services, such as emergency, outpatient, inpatient, laboratorium, radiology, medical rehab, pharmacy, and MCU; and general surgery, internist, VCT, ICU, cardiology, urology, haemodialysis, m… Read more